Table 1.
Clinical characteristics of SARS-CoV-2 population in living and deceased subjects.
| Observed Outcome | |||||
|---|---|---|---|---|---|
| Variable | Overall N = 694 | Alive N = 537 (77%) |
Deceased N = 157 (23%) |
Statistic | p-Value 1 |
| Age | 213 | <0.001 | |||
| Median (Range) | 64 (20–107) | 59 (20–94) | 80 (51–107) | ||
| Gender, n (%) | 0.07 | 0.8 | |||
| Female | 247 (36%) | 193 (36%) | 54 (34%) | ||
| Male | 447 (64%) | 344 (64%) | 103 (66%) | ||
| Hospital stay | 10 | 0.001 | |||
| Median (Range) | 11 (3–86) | 10 (3–86) | 13 (3–62) | ||
| CT findings, n (%) | 11 | 0.001 | |||
| Negative/Atypical | 284 (41%) | 238 (44%) | 46 (29%) | ||
| Typical | 410 (59%) | 299 (56%) | 111 (71%) | ||
| C-reactive protein | 19 | <0.001 | |||
| Median (Range) | 3 (0–37) | 3 (0–27) | 5 (1–37) | ||
| Lactate dehydrogenase | 97 | <0.001 | |||
| Median (Range) | 486 (78–3745) | 484 (78–3745) | 494 (141–3631) | ||
| D-dimer | 68 | <0.001 | |||
| Median (Range) | 1133 (96–152,015) | 1133 (96–55,660) | 6006 (168–152,015) | ||
1 One-way ANOVA; Pearson’s chi-squared test.